Brinker Capital Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Buy
4,713
+308
+7% +$105K 0.01% 882
2025
Q4
$1.75M Sell
4,405
-993
-18% -$439K 0.01% 925
2025
Q3
$2.46M Buy
5,398
+1,089
+25% +$443K 0.02% 729
2025
Q2
$1.41M Buy
4,309
+452
+12% +$125K 0.01% 987
2025
Q1
$1.04M Buy
3,857
+113
+3% +$29K 0.01% 1062
2024
Q4
$881K Buy
3,744
+203
+6% +$53.4K 0.01% 1122
2024
Q3
$974K Buy
3,541
+457
+15% +$119K 0.01% 1049
2024
Q2
$749K Buy
3,084
+939
+44% +$148K 0.01% 1114
2024
Q1
$321K Sell
2,145
-384
-15% -$64.1K ﹤0.01% 1436
2023
Q4
$498K Sell
2,529
-56
-2% -$9.54K 0.01% 1212
2023
Q3
$458K Buy
2,585
+229
+10% +$43.7K 0.01% 1231
2023
Q2
$447K Sell
2,356
-128
-5% -$25.4K ﹤0.01% 1252
2023
Q1
$498K Sell
2,484
-28
-1% -$5.89K 0.01% 1143
2022
Q4
$597K Sell
2,512
-141
-5% -$30.1K 0.01% 918
2022
Q3
$531K Buy
2,653
+160
+6% +$30.5K 0.01% 928
2022
Q2
$364K Sell
2,493
-281
-10% -$39.9K 0.01% 1091
2022
Q1
$453K Sell
2,774
-48
-2% -$7.31K 0.01% 1084
2021
Q4
$479K Buy
2,822
+349
+14% +$64.9K 0.01% 1067
2021
Q3
$419K Hold
2,473
0.01% 1031
2021
Q2
$419K Buy
2,473
+558
+29% +$81.7K 0.01% 1090
2021
Q1
$270K Buy
+1,915
New +$288K ﹤0.01% 1079
2020
Q1
Sell
-600
Closed -$69K 318
2019
Q4
$69K Hold
600
﹤0.01% 389
2019
Q3
$48K Hold
600
﹤0.01% 433
2019
Q2
$44K Hold
600
﹤0.01% 604
2019
Q1
$56K Sell
600
-540
-47% -$45.2K ﹤0.01% 455
2018
Q4
$83K Hold
1,140
﹤0.01% 357
2018
Q3
$100K Hold
1,140
﹤0.01% 323
2018
Q2
$112K Hold
1,140
﹤0.01% 326
2018
Q1
$136K Buy
+1,140
New +$147K ﹤0.01% 302
2015
Q3
Sell
-37
Closed -$4K 453
2015
Q2
$4K Buy
+37
New +$4.42K ﹤0.01% 394

Other funds holding ALNY